SCCT’s 19th Annual Scientific Meeting
Personalized Cardiac Care
with AI-Enabled Solutions
Thank you for a fantastic SCCT2024!
Cleerly was proud to return as diamond partners and sponsor the SCCT Clinical Trials & Registries Award, as well as events throughout the conference.
The 19th Annual Scientific Meeting was buzzing with incredible energy and developing research. We were thrilled to see the growing interest in the diagnostic power of combining CCTA with AI analysis for the detection of atherosclerosis and coronary artery disease.
If you didn't get a chance to visit us at the conference, we invite you to request a virtual demo of the Cleerly software platform. Experience firsthand how our technology simplifies the measurement of atherosclerosis, stenosis, and likelihood of ischemia. Our analysis delivers actionable insights that can aid you in efficiently and effectively devising the right course of treatment for your patients.
Check out some of the conference highlights below. We can't wait to connect with you again in 2025!
Cleerly's SCCT Events
Demonstrations daily // Friday and Saturday at Booth 201
Thursday, July 18
8:30AM – 6:00PM
AI/ML Hands-on Workshop
12:30PM – 1:30PM
Group one
Economics of AI/ML and Commercialization with Cleerly's CMO, James Earls, MD, FSCCT
2:00PM – 2:10PM
Cleerly presents
Prevention to Intervention: All in One Evaluation of Coronary Artery Disease, James K. Min, MD, MSCCT
2:30PM – 3:30PM
Group two
Economics of AI/ML and Commercialization with Cleerly's CMO, James Earls, MD, FSCCT
Friday, July 19
7:55AM – 9:35AM
Opening Session
SCCT Clinical Trials & Registries Award supported by Cleerly
9:00AM – 11:45AM
Exhibit hall open // Cleerly Booth 201
12:45AM – 7:30PM
Exhibit hall open // Cleerly Booth 201
5:05PM
Novel Technologies
Prevention to Intervention: All in One Evaluation of Coronary Artery Disease
James K. Min, MD, MSCCT
Saturday, July 20
9:00AM – 12:00PM
Exhibit hall open // Cleerly Booth 201
12:00PM – 1:00PM
Cleerly Lunch Symposium
Prevention to Intervention: Cleerly's All in One Care Pathway for Coronary Artery Disease
Moderator: James Min, MD, MSCCT
Speakers: Maros Ferencik, MD, PhD, MCR, MSCCT, Victor Cheng, MD, and Yader Sandoval, MD
1:00PM – 5:00PM
Exhibit hall open // Cleerly Booth 201
1:40PM – 1:50PM
AI/ML for Stenosis and Atherosclerosis Assessment
Nick Nurmohamed, MD
3:00PM – 4:00PM
Meet Cleerly Leadership
4:00PM – 4:10PM
General Session — Cardiac CT in Clinical Trials
TRANSFORM Trial
Koen Nieman, MD, PhD, MSCCT
Patents
Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology. Cleerly invests significant time and resources in research and development towards this goal. To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio – all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.
Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 11,922,627, 11,948,301, 12,023,190, 11,861,833, 11,967,078, 11,832,982, 11,690,586, 11,779,292, 11,730,437, 11,672,497, 11,737,718, 11,751,826, 11,660,058, 11,896,415, 11,751,830, 11,751,829, 11,302,001, 11,308,617, 11,238,587, 11,302,002, 11,321,840, 11,341,644, 11,244,451, 11,288,799, 11,276,170, 11,210,786, 11,232,564, 11,367,190, 11,315,247, 11,969,280, 11,094,060, 11,120,550, 11,120,549, 11,132,796, 11,094,061, 11,113,811, 11,501,436, 11,751,831, 11,642,092, 11,759,161, 11,317,883, 11,350,899, 11,766,230, 11,766,229, and 10,813,612, as well as other patents that are pending.
For additional information, please contact legal@cleerlyhealth.com.